Risk Assessment

Accurate Peripheral Neuropathy Detection for Healthcare Organizations

The Hidden Cost of Undiagnosed Peripheral Neuropathy

Peripheral neuropathy represents a significant but often unrecognized risk in healthcare populations. The prevalence of peripheral neuropathy in the general population is 10% and in patients over 65 it increases up to 30%1. Over 50% of patients with diabetes will develop neuropathy2. However, the rate of diagnosed neuropathy is often much lower than the prevalence rate, resulting in unidentified risk that can lead to costly complications and adverse outcomes.

This gap between actual prevalence and diagnosis creates hidden liabilities for risk-based organizations, managed care providers, and health assessment programs who need accurate member risk stratification.

Why Current Screening Methods Miss Critical Cases

Traditional peripheral neuropathy detection relies on basic screening tools that have significant limitations:

  • Monofilament and tuning fork tests detect only late-stage neuropathy and have low sensitivity3
  • Due to the subjective nature of these tests, they are usually performed by physicians rather than staff, limiting screening capacity
  • Compliance rates for the performance of these tests are typically poor in clinical practice
  • Up to 50% of diabetic peripheral neuropathies may be asymptomatic2, making symptom-based screening insufficient
  • Result: Peripheral neuropathy often has no clear signs or symptoms2, leading to delayed diagnosis and increased risk exposure

DPNCheck: Point-of-Care Nerve Conduction Testing

DPNCheck brings the gold standard of peripheral neuropathy diagnosis to the point of care through sural nerve conduction testing. Unlike traditional screening methods, sural nerve conduction detects peripheral neuropathy with high diagnostic sensitivity at all stages of severity.

Easy Operation & Implementation

  • 30-60 seconds per test
  • Easily implemented in clinic or home settings by medical assistants or other staff
  • Reports standard, readily understood nerve conduction parameters
  • Embedded quality control to ensure integrity of results
  • Minimal training required for staff implementation

Learn more about the complete testing procedure or understand how to interpret DPNCheck results.

DPNCheck device being used for peripheral neuropathy testing on patient's leg

DPNCheck is Ideal for Risk Assessment Programs

DPNCheck can improve the effectiveness of neuropathy detection programs and is ideal for multiple healthcare organization types:

Risk Based Organizations

  • Accurately identify and stratify member risk levels
  • Reduce exposure to undiagnosed neuropathy-related complications
  • Improve actuarial accuracy in risk assessment models
  • Enable proactive intervention strategies

Clinic Based Health Risk Assessments

  • Integrate objective neuropathy testing into routine health screenings
  • Identify high-risk patients for targeted care management
  • Improve preventive care protocols and outcomes
  • Support population health initiatives with accurate data

Health Risk Assessment Service Providers for In-home Use

  • Expand service offerings with advanced diagnostic capabilities
  • Provide clients with comprehensive risk assessment data
  • Differentiate services through objective, quantitative testing
  • Enable remote and in-home testing with portable technology

Specific Benefits for Managed Care Organizations

  • Accurately risk assess members with objective, quantitative data
  • Early diagnosis of peripheral neuropathy presents opportunities to intervene and reduce long-term costs
  • Identify patients with neuropathy who are at highest risk for neuropathy-related complications such as foot ulcers, neuropathic pain, and falls
  • Efficient and cost-effective testing that can be performed by staff
  • Support value-based care initiatives with improved risk stratification

Explore the complete clinical benefits of DPNCheck for healthcare organizations.

DPNCheck test results screen showing nerve conduction measurements

Easy Implementation & Training

DPNCheck is designed for seamless integration into existing workflows:

  • Minimal training required: Most staff can be trained to perform tests in a brief session
  • Staff-friendly operation: Medical assistants and other healthcare staff can perform tests independently
  • Quick testing: Each test takes only 30-60 seconds to complete
  • Quality assurance: Built-in quality control ensures reliable results
  • Flexible deployment: Suitable for clinic, mobile, or in-home use
View Training Videos

DPNCheck Clinical Validation

DPNCheck has been clinically validated in numerous peer-reviewed journal publications and clinical conference presentations, demonstrating high sensitivity and specificity for detecting peripheral neuropathy.

View Complete List
DPNCheck clinical validation studies and research publications

Ready to Improve Your Risk Assessment Program?

Learn more about implementing DPNCheck in your organization or get started with training resources.

Contact Us Training Resources Request a DPNCheck Quote

References

  1. Hicks, C.W., Wang, D., Windham, B.G. et al. Prevalence of peripheral neuropathy defined by monofilament insensitivity in middle-aged and older adults in two US cohorts. Sci Rep; 11, 19159, (2021)
  2. Pop-Busui R, Boulton AJ, Feldman EL, et al. Diabetic neuropathy: a position statement by the American Diabetes Association. Diabetes Care. 2017;40(1):136–154
  3. Perkins, et al. Simple Screening tests for Peripheral Neuropathy in the Diabetes Clinic. Diabetes Care. 24: 250-256, 2001.